Check out your Company Bowl for anonymous work chats.
ConcertAI today announced the acquisition of CancerLinQ, previously a subsidiary of the American Society of Clinical Oncology (ASCO). In conjunction with the acquisition, ASCO will maintain a multi-year cooperation agreement with CancerLinQ. Building on CancerLinQ's mission when launched by ASCO in 2013, this new venture will enhance and expand CancerLinQ's use of real-world data, analytics, next-generation AI, and other technologies to improve cancer care and speed clinical research.
The Harry Glorikian Show, where we dive into the tech-driven future of healthcare.
Check out the ConcertAI Blog!
Dive into the innovative world of oncology research with The ConcertAI Podcast! ConcertAI uses artificial intelligence to revolutionize the clinical development and delivery of cancer treatments, accelerating the delivery of precision oncology to patients in need. With real-world data, clinical trial matching, patient support, and more, ConcertAI is transforming the oncology landscape. These are rapidly changing fields which require very high expertise. Tune in twice a month as we bring subject matter experts together to take a deeper dive on topics of interest and relevance.To learn more about ConcertAI please visit us at www.ConcertAI.com
ConcertAI, LLC, a leading oncology real-world evidence data and AI technology company, and NeoGenomics, Inc., a leading oncology testing services company, today announced a broad collaboration to advance large-scale hematological research solutions to investigate real-world clinical practice and outcomes in hematological malignancies.
ConcertAI's Digital Trial Solution feat. BMS Exploring the adoption of innovative technologies and methodologies, the video series delves into enhancing clinical research through advanced cloud and edge technologies, aimed at improving patient identification and ensuring data security. It addresses operational efficiencies by reducing startup times and simplifying data collection, advocating for the use of comprehensive tools that integrate seamlessly with existing systems to avoid additional complexities. Highlighting a shift towards data-driven verification processes, these discussions underscore the pivotal role of technology in streamlining clinical research, ensuring accuracy, and facilitating better collaboration between research sites and sponsors.
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research | ConcertAI.
ConcertAI is sponsoring a research award intended to inform strategies to eliminate cancer health disparities. This award will provide early-stage research investigators with resources to investigate disparities in cancer care.
ConcertAI Announces Collaboration with Novartis to Use Real-World Data and AI Analytics to Optimize Cancer Care and Improve Patient Outcomes.
Join ConcertAI in an exciting new chapter of growth. We are continuing to hire across all teams, check out our career page and let's connect!
